<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221223056899N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-12-28</date_registration>
      <primary_sponsor>Birjand University of Medical Sciences</primary_sponsor>
      <public_title>The effect of acupressure on anxiety, fatigue and blood pressure</public_title>
      <acronym></acronym>
      <scientific_title>The effect of acupressure on anxiety, fatigue and blood pressure in patients undergoing hemodialysis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>105</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/67585</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: All sample people are divided into three equal groups by simple random method. First, 105 cards (the same as the sample size) will be prepared. Then, one of the letters A, B or C will be written on each card. These cards will be placed inside a box so that nobody can see the cards inside the box. After the researcher shuffles the cards, the patients are asked to randomly pick a card from the box (the selected cards are not returned to the box after selection). In this way, people are placed in three groups of 35 people A, B and C. In this way, three cards are prepared and one of the numbers 1, 2 and 3 will be written on each card. Number 1, 2 and 3 will belong to intervention, sham and control respectively. These cards are placed in a box and after mixing, the researcher will randomly select one card for each group (the selected cards will not return to the box after selection), Blinding description: The patients are divided into three intervention groups, sham points and control. The patients of the intervention group receive acupressure in real points and sham acupressure spheres in false points. The patients do not know the exact location of the points. In this study, the researcher's help in completing All questionnaires will be used for blinding and to prevent bias in the results. In this way, the researcher's help will be unaware of the groupings and the type of interventions that are carried out in each group and by each person.</study_design>
      <phase>3</phase>
      <hc_freetext>Renal failure.</hc_freetext>
      <i_freetext>Intervention 1: The patients of acupressure group are massaged at PC6 or Nei Guan points, GV 20 and ST36 (both legs) in total (9 points) by the thumb pulp of the therapist's hand and at the beginning of dialysis, which does not interfere with the patient's dialysis. The pressure level is 3 to 4 kg for 10 minutes. It will be done three times a week for 4 weeks. Follow-up is also done in the dialysis sessions, which the patient is definitely present. Intervention 2: Control group: Sham points group patients will receive acupressure on false points where applying pressure does not have any soothing effect, in the form of massage on two SP9 points that are inside the leg at the junction of the tibial shaft and the tibial condyle in a depression (to instead of ST36) and point CV24, which is exactly between the chin and lower lip on the front midline of the body in the middle of the distance between lip and chin (instead of GV20) and point SP6 (instead of LV3) and point KI27 (instead of GB 20) and point TW 6 (instead of PC6) will be performed by the therapist's thumb pulp with a pressure of 3 to 4 kg for 10 minutes three times a week for 4 weeks. Intervention 3: Control group: In the control group, no intervention will be performed on the patients.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Patient information is private.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Toktam Soleimani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.24,Ghaem29/1Ave</address>
        <city>Torbat-Heydariyeh</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9518656667</zip>
        <telephone>+98 51 5223 9677</telephone>
        <email>soleimanitoktam1374@gmail.com</email>
        <affiliation>Birjand University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Toktam Soleimani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.24,Ghaem29/1Ave</address>
        <city>Torbat-Heydariyeh</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9518656667</zip>
        <telephone>+98 51 5223 9677</telephone>
        <email>soleimanitoktam1374@gmail.com</email>
        <affiliation>Birjand University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Dialysis at least 2 times a week and each time for 3-4 hours
Dialysis treatment for at least 6 months
willingness to cooperate in the study
no use of sedatives such as benzodiazepines
Hearing ability and speech
No limb amputation or wound at the place of massage
No  contraindications to acupressure
Age at least 18 years</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Hospitalization of the patient during intervention
Suffering from hemodynamic complications in most dialysis sessions
The occurrence of a severe stressful event, such as the death of a first-degree relative
Travel or death of the patient
Unwillingness to continue cooperation in the study
Performing kidney transplant or peritoneal dialysis during research</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N17-N19</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The patients of acupressure group are massaged at PC6 or Nei Guan points, GV 20 and ST36 (both legs) in total (9 points) by the thumb pulp of the therapist's hand and at the beginning of dialysis, which does not interfere with the patient's dialysis. The pressure level is 3 to 4 kg for 10 minutes. It will be done three times a week for 4 weeks. Follow-up is also done in the dialysis sessions, which the patient is definitely present.</i_keyword>
      <i_keyword>Control group: Sham points group patients will receive acupressure on false points where applying pressure does not have any soothing effect, in the form of massage on two SP9 points that are inside the leg at the junction of the tibial shaft and the tibial condyle in a depression (to instead of ST36) and point CV24, which is exactly between the chin and lower lip on the front midline of the body in the middle of the distance between lip and chin (instead of GV20) and point SP6 (instead of LV3) and point KI27 (instead of GB 20) and point TW 6 (instead of PC6) will be performed by the therapist's thumb pulp with a pressure of 3 to 4 kg for 10 minutes three times a week for 4 weeks.</i_keyword>
      <i_keyword>Control group: In the control group, no intervention will be performed on the patients.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Reducing the level of anxiety. Timepoint: Before the start of the intervention, after the end of the intervention and one month after the end of the intervention. Method of measurement: Spielberger anxiety questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Reducing the fatigue level of hemodialysis patients. Timepoint: Before and after the intervention. Method of measurement: Paper fatigue questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Birjand University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-03-09</approval_date>
        <contact_name>Ethics Committee of Birjand University of Medical Sciences</contact_name>
        <contact_address>No.24,Ghaem29/1 Ave Torbat-Heydariyeh Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
